Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection

Annals of Surgical Oncology

Volumn 16, Issue 9, 2009, Pages 2516-2523

  Tang, Reiping ^a   Yeh, Chien Yuh ^a   Wang, Jeng Yi ^a   Changchien, Chung Rong ^a   Chen, Jinn Shiun ^a   Hsieh, Ling Ling ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; P53 ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; SEROCONVERSION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 68949201486     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0578-2     Document Type: Article

References (39)

1. I Chau MJ Allen D Cunningham et al 2004 The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer J Clin Oncol 22 1420 1429
2. GY Locker S Hamilton J Harris et al 2006 ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 2433 5313 5327
3. MJ Duffy A van Dalen C Haglund et al 2007 Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use Eur J Cancer 43 1348 1360
4. F Borie JP Daures B Millat B Tretarre 2004 Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study J Gastrointest Surg. 8 552 558
5. H Korner K Soreide PJ Stokkeland JA Soreide 2007 Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis Ann Surg Oncol 14 417 423
6. B Hanke C Riedel S Lampert et al 2001 CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid Ann Oncol 12 221 226
7. JY Wang SR Lin DC Wu et al 2007 Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels Clin Cancer Res. 13 2406 2413
8. MC von Brevern MC Hollstein HM Cawley et al 1996 Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors Cancer Res 56 4917 4921
9. CM Wu R Tang JR Chen et al 2004 Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan Oncol Rep. 12 1045 1051
10. Y Shibata H Kotanagi H Andoh K Koyama H Itoh S Kudo 1996 Detection of circulating anti-p53 antibodies in patients with colorectal carcinoma and the antibody's relation to clinical factors Dis Colon Rectum 39 1269 1274
11. H Wunderlich W Hindermann M Huller et al 2000 The correlation of p53 protein overexpression and p53 antibodies in serum of patients with transitional cell carcinoma of the urinary bladder Urol Int 64 13 17
12. CP Wild M Ridanpaa S Anttila et al 1995 p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue Int J Cancer 64 176 181
13. R Lubin B Schlichtholz D Bengoufa et al 1993 Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface Cancer Res 53 5872 5876
14. JP Peyrat J Bonneterre R Lubin L Vanlemmens J Fournier T Soussi 1995 Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer Lancet 345 621 622
15. G Zalcman J Tredaniel B Schlichtholz et al 2000 Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer Int J Cancer 89 81 86
16. PV Murray T Soussi ME O'Brien et al 2000 Serum p53 antibodies: predictors of survival in small-cell lung cancer? Br J Cancer 83 1418 1424
17. V Chow AP Yuen KY Lam WK Ho WI Wei 2001 Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma Head Neck 23 286 291
18. U Kressner B Glimelius R Bergstrom L Pahlman A Larsson G Lindmark 1998 Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer Br J Cancer 77 1848 1851
19. RN Sainger MH Shah AA Desai et al 2006 Clinical significance of serum p53 antibodies in oral cancer Tumori. 92 134 139
20. HY Cai XH Wang Y Tian LY Gao LJ Zhang ZY Zhang 2008 Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma World J Gastroenterol 14 4082 4086
21. MR Rosenfeld N Malats L Schramm et al 1997 Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer J Natl Cancer Inst 89 381 385
22. T Morita N Tachikawa T Kumamaru et al 2000 Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients Eur Urol 37 79 84
23. SC Chang JK Lin TC Lin WY Liang 2005 Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma Int J Oncol. 26 65 75
24. T Soussi 2000 p53 Antibodies in the sera of patients with various types of cancer: a review Cancer Res 60 1777 1788
25. T Nozoe M Yasuda M Honda S Inutsuka D Korenaga 2007 Clinicopathologic significance in serum presence of anti-p53 antibody in patients with colorectal carcinoma Hepatogastroenterology 54 1422 1425
26. R Tang MC Ko JY Wang et al 2001 Humoral response to p53 in human colorectal tumors: a prospective study of 1, 209 patients Int J Cancer 94 859 863
27. H Shimada A Takeda M Arima et al 2000 Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma Cancer 89 1677 1683
28. E Gumus G Demirel O Tanriverdi K Horasanli G Ozmen C Miroglu 2004 Importance of serum p53 antibodies during follow-up after treatment of invasive bladder tumors Urol Int 72 292 298
29. A Gadducci M Ferdeghini F Buttitta et al 1998 Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma Anticancer Res 18 3763 3765
30. P Hammel B Boissier MT Chaumette et al 1997 Detection and monitoring of serum p53 antibodies in patients with colorectal cancer Gut. 40 356 361
31. JY Wang R Tang JM Chiang 1994 Value of carcinoembryonic antigen in the management of colorectal cancer Dis Colon Rectum 37 272 277
32. JY Park KH Lee 2007 Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer Hepatogastroenterology 54 1966 1969
33. I Grossmann GH de Bock WM Meershoek-Klein Kranenbarg CJ van de Velde T Wiggers 2007 Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial Eur J Surg Oncol 33 183 187
34. A Takeda H Shimada K Nakajima et al 2001 Serum p53 antibody as a useful marker for monitoring of treatment of superficial colorectal adenocarcinoma after endoscopic resection Int J Clin Oncol. 6 45 49
35. SH van der Burg K de Cock AG Menon et al 2001 Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer Eur J Immunol 31 146 155
36. A Forslund U Kressner G Lindmark M Inganas K Lundholm 2001 Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas Int J Oncol. 19 501 506
37. R Lubin G Zalcman L Bouchet et al 1995 Serum p53 antibodies as early markers of lung cancer Nat Med 1 701 702
38. R Lubin B Schlichtholz JL Teillaud E Garay A Bussel CP Wild 1995 p53 antibodies in patients with various types of cancer: assay, identification, and characterization Clin Cancer Res. 1 1463 1469
39. S Yoshizawa K Matsuoka N Inoue et al 2007 Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis Inflamm Bowel Dis. 13 865 873